акш. Министерство Здравоохранения Российской Федерации Российское общество кардиосоматической реабилитации и вторичной
 Скачать 1.05 Mb.
|
|
. Journal of Cardiac Surgery.2013; 28 (2): 109-16. DOI: 10.1111/jocs.12074 79. Devereaux PJ, Goldman L, Yusuf S, et al. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ 2005; 173: 779–88. 170 80. Eagle KA, Guyton RA, Davidoff R, Edwards FH, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004; 110 (14): e340-437. 81. El-Ansary D, Waddington G, Adams RT Runk stabilisation exercises reduce sternal separation in chronic sternal instability after cardiac surgery: a randomised cross-over trial. Aust J Physiother. 2007; 53 (4): 255-60. 82. Engblom E, Korpilahti K, Hamalainen H, et al. Quality of life and return to work 5 years after coronary artery bypass surgery. Long-term results of cardiac rehabilitation. J Cardiopulm Rehabil. 1997; 17:29 –36. 83. Fabricius AM, Gerber W, Hanke M, Garbade J, Ru¨diger A, Mohr F. Early angiographic control of perioperative ischemia after coronary artery bypass grafting. Eur J Cardio- thorac Surg. 2001; 19: 853–8. 84. Farooq V, Serruys PW, Bourantas C, Vranckx P, Diletti R, Garcia Garcia HM, Holmes DR, Kappetein AP, Mack M, Feldman T, Morice MC, Colombo A, Morel MA, de Vries T, van Es GA, Steyerberg EW, Dawkins KD, Mohr FW, James S, Stеhle E. Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) trial. Eur Heart J. 2012; 33: 3105–13. doi: 10.1093/eurheartj/ehs367. 85. Echahidi N., Pibarot P., O’Hara G., Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. JACC 2008; 26: 51(8): 793–801. 86. Ferguson TB, Coombs LP, Peterson ED. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002; 287: 2221–7. 87. Ferreira GM, Haeffner MP, Barreto SS, Dall'Ago P. Incentive spirometry with expiratory positive airway pressure brings benefits after myocardial revascularization. Arq Bras Cardiol. 2010; 94 (2): 230-5. 88. Fihn SD, Gardin JM, Abrams J. et al. 2012 ACCF/AHA/ACP/ AATS/PCNA/SCAI/ STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart 171 Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012; 18; 60 (24): e44-e164. 89. Fox KM, Bertrand ME, Remme WJ, et al. efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease. Am Heart J. 2007;153: 629 –35. 90. Friedman S. Cardiac disease, anxiety, and sexual functioning. Am J Cardiol. 2000; 86: 46F–50F. 91. Foruzan-Nia SK, Abdollami MH, Hekmatimoghaddam SH et al.. Incidence of sexual dysfunction in men after cardiac surgery in Afshar hospital, Yazd. Iran J Reproductive Medicine. 2011; 9 (2): 89-94. 92. Fuster V, Ryde´n LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123: e269–367. 93. Gallagher R, McKinley S. Anxiety, depression and perceived control in patients having coronary artery bypass grafts. J Adv Nurs. 2009; 65: 2386-96. doi: 10.1111/j.1365- 2648.2009.05101.x. 94. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005; 80: 862– 6. 95. Geraci SA, Haan CK. Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature? Ann Thorac Surg. 2002; 74(5):1727-32. 96. Gianuzzi P. Saner H. et al. Secondary prevention through cardiac rehabilitation. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur. Heart J. 2003; 24: 1273-8. 97. Ghroubi S, Elleuch W, Abid L, Abdenadher M, Kammoun S, Elleuch MH. Effects of a low-intensity dynamic-resistance training protocol using an isokinetic dynamometer on 172 muscular strength and aerobic capacity after coronary artery bypass grafting. Ann Phys Rehabil Med. 2013; 56 (2): 85-101. 98. Goldenberg I, Jonas M, Tenenbaum A, et al. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med. 2003;163: 2301–5. 99. Connerney I, Shapiro PA, McLaughlin JS, et al. Relation between depression after coronary artery bypass surgery and 12- month outcome: a prospective study. Lancet. 2001; 358: 1766-71. 100. Gottesman RF, Grega MA, Bailey MM, et al. Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol. 2010; 67: 338–44. 101. Goyal TM, Idler EL, Krause TJ, Contrada RJ. Quality of life following cardiac surgery: impact of the severity and course of depressive symptoms. Psychosom Med. 2005; 67: 759–65. doi: 10.1097/01.psy.0000174046.40566.80. 102. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014;129: 1972–86. doi: 10.1161/CIRCULATIONAHA.114.007667. 103. Gundle MJ, Reeves BR Jr, Tate S, Raft D, McLaurin LP. Psychosocial outcome after coronary artery surgery. Am J Psychiatry. 1980;137: 1591–4. 104. Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation. 2009; 120: 2577–85. 105. Haeffener MP, Ferreira GM, Barreto SS, et al. Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications, improves pulmonary function and 6–minute walk distance in patients undergoing coronary artery bypass graft surgery. Am Heart J. 2008; 156: 900 e1– 8. 106. Hällberg V, Palomäki A, Kataja M, Tarkka M, Hällberg V, Palomäki A, Kataja M, Tarkka M. Return to work after coronary artery bypass surgery. A 10-year follow-up study. Scand Cardiovasc J. 2009; 43(5): 277-84. 107. Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation. 2010; 121: 63–70. 173 108. Hansen D, Dendale P, Leenders M, et al. Reduction of cardiovascular event rate: different effects of cardiac rehabilitation in CABG and PCI patients. Acta Cardiol. 2009; 64: 639–44. 109. Hansson E.C. Jide´us L, Åberg B, Bjursten H, et al. Coronary artery bypass grafting- related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J. 2015; doi:10.1093/eurheartj/ehv381. 110. Head SJ, Kieser TM, Falk V, Huysmans HA, Kappetein AP. Coronary artery bypass grafting: Part 1--the evolution over the first 50 years. Eur Heart J. 2013; 34 (37): 2862- 72. 111. Hedges C, Redeker NS. Comparison of sleep and mood in patients after on-pump and off-pump coronary artery bypass surgery. Am J Crit Care. 2008;17:133–40. 112. Heidbuchel H, Corrado D, Biffi A. et al. Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions, part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc PrevRehabil. 2006; 13: 676–86. 113. Held C, Asenblad N, Bassand JP, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery. Results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2010; 57:672– 84. 114. Herdy AH, Marcchi PL, Vila A, Tavares C, Collaço J, Niebauer J, Ribeiro JP. Pre- and postoperative cardiopulmonary rehabilitation in hospitalized patients undergoing coronary artery bypass surgery: a randomized controlled trial. Am J Phys Med Rehabil. 2008; 87 (9): 714-9. 115. Hilleman DE, Mohiuddin SM, Packard KA. Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest. 2004;125: 435–8. 116. Ho K.M., Tan J.A. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose–response meta-analysis. Circulation 2009; 119: 1853–66. 174 117. Ho PM, Arciniegas DB, Grigsby J, McCarthy M Jr, McDonald GO, Moritz TE, Shroyer AL, Sethi GK, Henderson WG, London MJ, VillaNueva CB, Grover FL, Hammermeister KE. Predictors of cognitive decline following coronary artery bypass graft surgery. Ann Thorac Surg. 2004; 77: 597–603. doi: 10.1016/S0003-4975(03)01358-4. 118. Hulzebos EH, van Meeteren NL, van den Buijs BJ, de Bie RA, Brutel de la Rivière A, Helders PJ. Feasibility of preoperative inspiratory muscle training in patients undergoing coronary artery bypass surgery with a high risk of postoperative pulmonary complications: a randomized controlled pilot study. Clin Rehabil. 2006; 20 (11): 949-59. 119. Hulzebos EH, Helders PJ, Favié NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA. 2006; 296 (15): 1851-7. 120. Hudetz JA, Iqbal Z, Gandhi SD, et al. Postoperative delirium and short-term cognitive dysfunction occur more frequently in patients undergoing valve surgery with or without coronary artery bypass graft surgery compared with coronary artery bypass graft surgery alone: results of a pilot study. J Cardiothorac Vasc Anesth. 2011; 25:811– 6. 121. Jaarsma T, Steinke EE, Gianotten WL. Sexual problems in cardiac patients: how to assess, when to refer. J Cardiovasc Nurs. 2010; 25: 159–64. 122. January CT, Wann LS, Alpert JS, Calkins H, Cleveland Jr JC, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation, JAСC. 2014, doi: 10.1016/j.jacc.2014.03.022. 123. Ji Q., Mei Y., Wang X. et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J 2009; 73: 2244-9. 124. Johnson WD, Kayser KL, Hartz AJ, Saedi SF. Aspirin use and survival after coronary bypass surgery. Am Heart J. 1992; 123: 603–8. 125. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Antonnucio DO, Hartman N, McGovern PG. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996; 335: 1792–98. doi: 10.1056/NEJM199612123352402. 175 126. Kamiya K, Mezzani A, Hotta K, Shimizu R, Kamekawa D, Noda C, Yamaoka-Tojo M, Matsunaga A, Masuda T. Quadriceps isometric strength as a predictor of exercise capacity in coronary artery disease patients. Eur J Prev Cardiol. 2014; 21(10): 1285-91. doi: 10.1177/2047487313492252. 127. Karoff M, Röseler S, Lorenz C, Kittel J. Intensified after-care--a method for improving occupational reintegration after myocardial infarct and/or bypass operation. Z Kardiol. 2000; 89 (5): 423-33. 128. Khan MF, Wendel CS, Movahed MR. Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials. Ann Noninvasive Electrocardiol. 2013;18: 58–68. doi:10.1111/anec.12004. 129. Klein LW, Edwards FH, DeLong ER, et al. ASCERT: the American College of Cardiology Foundation--the Society of Thoracic Surgeons Collaboration on the comparative effectiveness of revascularization strategies. JACC Cardiovasc Interv. 2010; 3 (1): 124-6. 130. Kloner RA. Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation 2004;110: 3149 –55. 131. Kloner RА. Erectile dysfunction and hypertension. Int J Impot Res. 2007; 19: 296 –302. 132. Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, Costigan TM, Vail GM. Cardiovascular safety update of tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of tadalafil with as needed, three times-per-week or once-a-day dosing. Am J Cardiol. 2006; 97: 1778- 84. 133. Kloner RA, Hutter AM, Emmick JT. et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003; 42: 1855-60. 134. Knayzer B., Abramov D., Natalia B. et al. Atrial fibrillation and plasma troponin I elevation after cardiac surgery: relation to inflammation-associated parameters. J Card Surg. 2007; 22: 117-23. 135. Kocz R, Hassan MA, Perala PR, Negargar S, Javadzadegan H, Nader ND. The effect of weight loss on the outcome after coronary artery bypass grafting in obese patients. Ann Card Anaesth. 2012;15: 190–8.doi: 10.4103/0971-9784.97975. 176 136. Kriston L, Gunzler C, Agyemang A. et al. SPARK Study Group. Effect of sexual function on health-related quality of life mediated by depressive symptoms in cardiac rehabilitation: findings of the SPARK project in 493 patients. J Sex Med. 2010; 7: 2044 – 55. 137. Korzeniowska-Kubacka I, Piotrowicz R. Cardiological rehabilitation – a chance of returning to work. Med Pr. 2005; 56 (4): 325-7. 138. Kulik A, Ruel M. Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits? Curr Opin Cardiol. 2011; 26 (6): 508-17. 139. Kulik A, Voisine P, Mathieu P, Masters RG, Mesana TG, Le May MR, Ruel M. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial. Ann Thorac Surg. 2011; 92: 1284-90. doi: 10.1016/j.athoracsur.2011.04.107. 140. Kulik A., Ruel M., Jneid H., Ferguson T.B., Hiratzka L.F., Ikonomidis J. S., Lopez- Jimenez F, McNallan SM, Patel M, Roger VL, Sellke FW, Sica DA, Zimmerman L. on behalf of the American Heart Association Council on Cardiovascular Surgery and Anesthesia Secondary prevention after coronary artery bypass graft surgery: A scientific statement from the American Heart Association. Circulation. 2015; 131 (10): 927-64. doi: 10.1161/CIR.0000000000000182. 141. Kwan G, Balady GJ. Cardiac Rehabilitation 2012 Advancing the Field Through Emerging Science, Circulation, 2012; 125: 369-73. 142. Lai YH, Hsieh SR,HoWC,Chiou AF. Factors associated with sexual quality of life in patients before and after coronary artery bypass grafting surgery. J Cardiovasc Nurs 2011; 26 :487–96. 143. Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009; 87: 663–9. 144. Lee I-M, Shiroma EJ, Lobelo F. Effect of physical inactivity on major non- communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380: 9838: 219–29. 145. Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB, Foster E, Jaarsma T, Kloner RA, Lange RA, Lindau ST, Maron BJ, Moser DK, Ohman EM, Seftel 177 AD, Stewart WJ; on behalf of the American Heart Association Council on Clinical Cardiology, Council on Cardiovascular Nursing, Council on Cardiovascular Surgery and Anesthesia, and Council on Quality of Care and Outcomes Research. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012; 125: 1058–72. 146. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith Jr SC, Focused Update Writing Group, 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease, JАCC. 2016, doi: 10.1016/j.jacc.2016.03.513. 147. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003; 75: S715–S720. 148. Liakopoulos O. J., Choi Y.-H., Haldenwang P. L. et al. Impact of preoperative statin therapy on adverse outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patients. Eur Heart J. 2008; 29:1548-59. 149. Lim E, Ali Z, Ali A, Routledge T, Edmonds L, Altman DG, Large S. Indirect comparison meta-analysis of aspirin therapy after coronary surgery . BMJ. 2003; 327:1309. 150. Lloyd-Jones DM., Morris PB.,. Ballantyne CM., Birtcher KК., Daly DD., DePalma SM., Minissian MB., Orringer CE., Smith SC. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents Endorsed by the National Lipid Association JACC. 2016; 6 8 (1): 92-125. 151. Lorenz RL, Schacky CV, Weber M, et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane ormation. Lancet. 1984;1:1261–4. 152. Lorusso R, Pentiricci S, Raddino R, Scarabelli TM, Zambelli C, Villanacci V, Burattin A, Romanelli G, Casari S, Scelsi R, Giustina A. Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. |